FDA Drug Application (010040) for RENOVIST II by BRACCO

Back to FDA Applications sponsored by BRACCO

Application Number010040
Product Number019
FormINJECTABLE;INJECTION
Dosage28.5%;29.1%
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRENOVIST II
Active IngredientDIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM



Back to FDA Applications sponsored by BRACCO

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.